Perspectives on smoking cessation in the oncology environment: insights from brazilian patients and healthcare providers
- PMID: 40802346
- PMCID: PMC12333894
- DOI: 10.1590/1980-549720250046
Perspectives on smoking cessation in the oncology environment: insights from brazilian patients and healthcare providers
Abstract
Objective: The aim of this study was to identify barriers and facilitators to smoking cessation among Brazilian cancer patients, considering the perspectives of both patients and healthcare professionals at a leading oncology center in the country.
Methods: A cross-sectional study was conducted, collecting smoking-related data from two groups: cancer patients and healthcare professionals at the Barretos Cancer Hospital (BCH) between 2019 and 2021. The questionnaire for healthcare professionals was adapted from the 2012 International Association for the Study of Lung Cancer and the Global Adult Tobacco Survey. For the cancer patient group, sociodemographic and clinical data were collected, along with the smoking history and consumption patterns of current smokers.
Results: Among oncology patients, the prevalence of former smokers was found to be 37.4%, while current smokers accounted for 16.8%. Most current smokers exhibited low nicotine dependence and high motivation to quit. Key barriers reported by healthcare professionals in providing smoking cessation interventions included patient resistance (86.9%) and lack of training (64.5%). Furthermore, 52.9% of these professionals indicated that they had never discussed cessation strategies during consultations with smoking patients. Regression models revealed that physicians, compared to other professionals, were more likely to address, advise, and offer cessation treatment to smoking patients (p≤0.05).
Conclusion: There is a need to enhance training on smoking cessation for healthcare professionals to improve clinical outcomes and survival rates among cancer patients.
Objetivo:: Identificar barreiras e facilitadores para a cessação do tabagismo entre pacientes oncológicos brasileiros, considerando as perspectivas dos pacientes e dos profissionais de saúde em um centro de referência em tratamento oncológico no país.
Métodos:: Estudo transversal que coletou dados sobre tabagismo de dois grupos, pacientes com câncer e profissionais de saúde, do Hospital de Câncer de Barretos (HCB), durante o período de 2019 a 2021. O questionário aplicado ao grupo de profissionais de saúde foi adaptado da International Association for the Study of Lung Cancer de 2012 e do Global Adult Tobacco Survey. Para o grupo de pacientes oncológicos, foram coletados dados sociodemográficos e clínicos, além do histórico e padrões de consumo de tabaco dos pacientes fumantes.
Resultados:: Foi observada prevalência de 37,4% de ex-fumantes e 16,8% de fumantes atuais entre os pacientes oncológicos. A maioria dos fumantes atuais apresentou baixa dependência de nicotina e alta motivação para a cessação. As principais barreiras relatadas pelos profissionais de saúde para a oferta de intervenções antitabagistas incluíram resistência dos pacientes (86,9%) e falta de treinamento (64,5%). Além disso, 52,9% desses profissionais nunca discutiram estratégias de cessação durante as consultas com pacientes fumantes. Os modelos de regressão demonstraram que os médicos, em comparação com outros profissionais, são mais propensos a abordar, aconselhar e oferecer tratamento de cessação aos pacientes fumantes (p≤0,05).
Conclusão:: Esforços devem ser direcionados para aprimorar o treinamento sobre cessação do tabagismo para profissionais de saúde, contribuindo para melhorar os resultados clínicos e a sobrevivência dos pacientes com câncer.
Conflict of interest statement
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Electronic cigarettes for smoking cessation and reduction.Cochrane Database Syst Rev. 2014;(12):CD010216. doi: 10.1002/14651858.CD010216.pub2. Epub 2014 Dec 17. Cochrane Database Syst Rev. 2014. PMID: 25515689
-
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590. Health Technol Assess. 2021. PMID: 34668482
-
Strategies to improve smoking cessation rates in primary care.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD011556. doi: 10.1002/14651858.CD011556.pub2. Cochrane Database Syst Rev. 2021. PMID: 34693994 Free PMC article.
-
Healthcare financing systems for increasing the use of tobacco dependence treatment.Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD004305. doi: 10.1002/14651858.CD004305.pub5. Cochrane Database Syst Rev. 2017. PMID: 28898403 Free PMC article.
References
-
- Lelaurin JH, Dallery J, Silver NL, Markham M-J, Theis RP, Chetram DK, et al. An implementation trial to improve tobacco treatment for cancer patients: patient preferences, treatment acceptability and effectiveness. Int J Environ Res Public Health. 2020;17(7):2280–2280. doi: 10.3390/ijerph17072280. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical